Conflict of interests: The authors declare no conflict of interest.
Randomized, multicenter, comparative study of NEURO versus CIMT in poststroke patients with upper limb hemiparesis: the NEURO-VERIFY Study
Article first published online: 9 SEP 2013
© 2013 The Authors. International Journal of Stroke © 2013 World Stroke Organization
International Journal of Stroke
How to Cite
Abo, M., Kakuda, W., Momosaki, R., Harashima, H., Kojima, M., Watanabe, S., Sato, T., Yokoi, A., Umemori, T. and Sasanuma, J. (2013), Randomized, multicenter, comparative study of NEURO versus CIMT in poststroke patients with upper limb hemiparesis: the NEURO-VERIFY Study. International Journal of Stroke. doi: 10.1111/ijs.12100
Funding: Funding for this study was provided by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.
- Article first published online: 9 SEP 2013
- Japan Society for the Promotion of Science
- constraint-induced movement therapy;
- occupational therapy;
- randomized controlled trial;
- repetitive transcranial magnetic stimulation;
- upper limb hemiparesis
Many poststroke patients suffer functional motor limitation of the affected upper limb, which is associated with diminished health-related quality of life.
The aim of this study is to conduct a randomized, multicenter, comparative study of low-frequency repetitive transcranial magnetic stimulation combined with intensive occupational therapy, NEURO (NovEl intervention Using Repetitive TMS and intensive Occupational therapy) versus constraint-induced movement therapy in poststroke patients with upper limb hemiparesis.
In this randomized controlled study of NEURO and constraint-induced movement therapy, 66 poststroke patients with upper limb hemiparesis were randomly assigned at 2:1 ratio to low-frequency repetitive transcranial magnetic stimulation plus occupational therapy (NEURO group) or constraint-induced movement therapy (constraint-induced movement therapy group) for 15 days. Fugl–Meyer Assessment and Wolf Motor Function Test and Functional Ability Score of Wolf Motor Function Test were used for assessment.
No differences in patients' characteristics were found between the two groups at baseline. The Fugl–Meyer Assessment score was significantly higher in both groups after the 15-day treatment compared with the baseline. Changes in Fugl–Meyer Assessment scores and Functional Ability Score of Wolf Motor Function Test were significantly higher in the NEURO group than in the constraint-induced movement therapy group, whereas the decrease in the Wolf Motor Function Test log performance time was comparable between the two groups (changes in Fugl–Meyer Assessment score, NEURO: 5·39 ± 4·28, constraint-induced movement therapy: 3·09 ± 4·50 points; mean ± standard error of the mean; P < 0·05) (changes in Functional Ability Score of Wolf Motor Function Test, NEURO: 3·98 ± 2·99, constraint-induced movement therapy: 2·09 ± 2·96 points; P < 0·05).
The results of the 15-day rehabilitative protocol showed the superiority of NEURO relative to constraint-induced movement therapy; NEURO improved the motion of the whole upper limb and resulted in functional improvement in activities of daily living.